Showing Form 4 filings for PBYI
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Puma Biotechnology, Inc.
Price
$8.10
Shares
15,000
Ownership
66,000
Value/Share
Miller Michael Patrick
Dir
Unknown
Industry
PBYI
$9.10
5,000
55,300
Wilson Troy Edward
$8.26
8,460
196,841
Hunt Douglas M
See Remarks
9,386
230,637
Nougues Maximo F
CFO
44,058
7,261,671
Auerbach Alan H
Pres, CEO, 10%
$7.20
8,100
113,858
Stuglik Brian M
27,000
Senderowicz Adrian
$7.22
22,000
58,322
Moyes Jay M
11,610
90,780
Dorval Allison
10,800
60,300
$5.86
8,987
155,907
10,945
193,284
34,950
7,145,951
$4.86
20,000
54,000
$3.37
41,850
Cesano Alessandra
$3.53
7,817
164,894
47,172
7,180,901
9,522
204,229
$3.39
94,958
$3.40
53,322
75,390
12,150
68,850
44,100
$3.15
9,437
108,951
Ludwig Jeffrey Jerome
Chief Commercial Officer
8,633
124,594
33,841
7,029,674
10,227
152,295